{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:43:19Z","timestamp":1764002599421,"version":"3.40.5"},"reference-count":28,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"Coordination for the Improvement of Higher Education Personnel, CAPES, Federal Government, Brazil","award":["88887.506617\/2020-00"],"award-info":[{"award-number":["88887.506617\/2020-00"]}]},{"name":"\u2018National Council for Scientific and Technological Development\u2019 \u2013CNPq, Research Productivity","award":["304747\/2018-1"],"award-info":[{"award-number":["304747\/2018-1"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.2217\/imt-2022-0048","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T08:36:01Z","timestamp":1673426161000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Comparing Bacillus Calmette-Gu\u00e9Rin (Bcg) Strains in Convalescent Covid-19 Patients"],"prefix":"10.1080","volume":"15","author":[{"given":"Mehrsa","family":"Jalalizadeh","sequence":"first","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane F","family":"Giacomelli","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia AF","family":"Leme","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keini","family":"Buosi","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana SB","family":"Dal Col","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciele AV","family":"Dionato","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane L","family":"Maia","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Yadollahvandmiandoab","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilson P","family":"Domingues-Junior","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-414X","authenticated-orcid":false,"given":"Leonardo O","family":"Reis","sequence":"additional","affiliation":[{"name":"UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil"},{"name":"Pontifical Catholic University of Campinas, PUC-Campinas, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"e_1_3_7_3_1","first-page":"73","article-title":"WHO BCG vaccines: WHO position paper \u2013 February 2018 \u2013 Vaccines BCG: note de synth\u00e8se de l\u2019OMS-F\u00e8vrier 20188","volume":"93","author":"World Health Organization","year":"2018","unstructured":"World Health Organization . WHO BCG vaccines: WHO position paper \u2013 February 2018 \u2013 Vaccines BCG: note de synth\u00e8se de l\u2019OMS-F\u00e8vrier 20188. Wkly Epidemiol Record Relev E\u2019pide\u2019miol Hebd.93, 73\u201396 (2018).","journal-title":"Wkly Epidemiol Record Relev E\u2019pide\u2019miol Hebd."},{"doi-asserted-by":"publisher","key":"e_1_3_7_4_1","DOI":"10.1073\/pnas.0700869104"},{"unstructured":"World Health Organization Expert Committee on Biological Standardization\n. Recommendations to assure the quality safety and efficacy of BCG vaccines. Replacement of Annex 2 of WHO Technical Report Series No. 745 and Amendment to Annex 12 of WHO Technical Report Series No. 771 (2013). https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/vaccine-standardization\/bcg-(tuberculosis)\/trs-979-annex-3-bcg-vax.pdf","key":"e_1_3_7_5_1"},{"doi-asserted-by":"publisher","key":"e_1_3_7_6_1","DOI":"10.1111\/iju.13538"},{"doi-asserted-by":"publisher","key":"e_1_3_7_7_1","DOI":"10.3390\/vaccines10010040"},{"unstructured":"UNICEF\n. Product Attributes Guide (2018). https:\/\/supply.unicef.org\/product-attributes-guide","key":"e_1_3_7_8_1"},{"doi-asserted-by":"publisher","key":"e_1_3_7_9_1","DOI":"10.1016\/j.vaccine.2008.10.058"},{"doi-asserted-by":"publisher","key":"e_1_3_7_10_1","DOI":"10.1164\/rccm.201104-0714OC"},{"doi-asserted-by":"publisher","key":"e_1_3_7_11_1","DOI":"10.1016\/j.cmi.2019.04.020"},{"key":"e_1_3_7_12_1","first-page":"1","article-title":"Effectiveness of booster BCG vaccination in preventing Covid-19 infection","volume":"22","author":"Amirlak L","year":"2021","unstructured":"Amirlak L , HaddadR , HardyJDet al. Effectiveness of booster BCG vaccination in preventing Covid-19 infection. Hum. Vaccin Immunother.22, 1\u20133 (2021).","journal-title":"Hum. Vaccin Immunother."},{"key":"e_1_3_7_13_1","first-page":"873067","article-title":"Activate-2: a double-blind randomized trial of BCG vaccination against COVID19 in individuals at risk","volume":"13","author":"Tsilika M","year":"2021","unstructured":"Tsilika M , TaksE , DolianitisKet al. Activate-2: a double-blind randomized trial of BCG vaccination against COVID19 in individuals at risk. MedRxiv13, 873067 (2021).","journal-title":"MedRxiv"},{"doi-asserted-by":"publisher","key":"e_1_3_7_14_1","DOI":"10.1016\/j.vaccine.2020.08.016"},{"unstructured":"Minist\u00e9rio da Sa\u00fade\n. Nota informativa N\u00b0 18\/2018-CGPNI\/DEVIT\/SVS\/MS. Presta orienta\u00e7\u00f5es sobre o uso da vacina BCG do laborat\u00f3rio Serum Institute of India Ltd. (2018). www.sgc.goias.gov.br\/upload\/arquivos\/2018-03\/sei_ms---2283326---nota-informativa-18-bcg.pdf","key":"e_1_3_7_15_1"},{"unstructured":"Serum Institute of India PVT. LTD\n. Products supplied overseas BCG vaccine (freeze-dried). www.seruminstitute.com\/product_diphtheriatetanus_bcg.php (Accessed 20February2022).","key":"e_1_3_7_16_1"},{"unstructured":"Fundacao Ataulpho de Paiva\n. Bula Profissional Vacina BCG. www.fundacaoataulphodepaiva.com.br\/bula-profissional-vacina-bcg\/ (Accessed 20February2022).","key":"e_1_3_7_17_1"},{"doi-asserted-by":"publisher","key":"e_1_3_7_18_1","DOI":"10.1111\/joim.13523"},{"doi-asserted-by":"publisher","key":"e_1_3_7_19_1","DOI":"10.1016\/j.vaccine.2022.06.039"},{"unstructured":"Aaby P BennCS Schaltz-BuchholzerF. Randomized trial evaluating the non-specific effects of different BCG strains in Guinea-Bissau: effects on early-life mortality and morbidity. Bandim Health Project. ClinicalTrials.gov.Last update: 26 May 2022 (NCT04383925). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04383925","key":"e_1_3_7_20_1"},{"unstructured":"Aaby P\n. Evaluating the effect of different BCG strains on early life hospital admissions in Guinea-Bissau: a randomised trial. bandim health project. ClinicalTrials.gov. Last update: 16 December 2020 (NCT02447536). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02447536","key":"e_1_3_7_21_1"},{"unstructured":"Aaby P\n. Evaluating the non-specific effects of different BCG strains in Guinea-Bissau: randomized trial of the impact on early-life hospital admissions and deaths. Bandim Health Project. ClinicalTrials.gov. Last update: 16 December 2020 (NCT03400878). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03400878","key":"e_1_3_7_22_1"},{"unstructured":"Svatek R\n. S1602 a phase III randomized trial to evaluate the influence of BCG strain differences and T cell priming with intradermal BCG before intravesical therapy for BCG-naive high-grade non-muscle invasive bladder cancer. Southwest Oncology Group. ClinicalTrials.gov Last Update: 10 March 2022 (NCT03091660). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03091660","key":"e_1_3_7_23_1"},{"unstructured":"Thalmann GN\n. A prospective randomized trial for the comparison of two BCG strains (bacille Calmette-Guerin) in the prophylaxis of papollary bladder tumors stage Ta and T1 and treatment of carcinoma in situ . Swiss Group for Clinical Cancer Research. ClinicalTrials.gov. Last update: 26 June 2019 (NCT00003779). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00003779","key":"e_1_3_7_24_1"},{"unstructured":"McShane HI\n. A study of the immunogenicity of M. Bovis BCG (SSI strain) delivered intradermally in healthy volunteers. University of Oxford UK. ClinicalTrials.gov. Last update: 31 May 2007 (NCT00480714). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00480714","key":"e_1_3_7_25_1"},{"doi-asserted-by":"publisher","key":"e_1_3_7_26_1","DOI":"10.1016\/j.vaccine.2019.11.060"},{"doi-asserted-by":"publisher","key":"e_1_3_7_27_1","DOI":"10.1016\/S0264-410X(98)00277-1"},{"doi-asserted-by":"publisher","key":"e_1_3_7_28_1","DOI":"10.1016\/S1473-3099(02)00182-2"},{"doi-asserted-by":"publisher","key":"e_1_3_7_29_1","DOI":"10.1128\/jcm.35.3.566-569.1997"},{"doi-asserted-by":"publisher","key":"e_1_3_7_30_1","DOI":"10.1111\/j.1574-695X.2009.00559.x"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2022-0048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:38:11Z","timestamp":1715953091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2022-0048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.2217\/imt-2022-0048"],"URL":"https:\/\/doi.org\/10.2217\/imt-2022-0048","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"type":"print","value":"1750-743X"},{"type":"electronic","value":"1750-7448"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}